Immix Biopharma Consensus Price Target Increased by 10.16% to $25.04

The average one-year price target for Immix Biopharma (NASDAQCM:IMMX) has been revised to $25.04 / share. This is an inc...

By Dhallo News · October 2, 2026 at 5:16 PM IST

The average one-year price target for Immix Biopharma (NASDAQCM:IMMX) has been revised to $25.04 / share. This is an increase of 10.16% from the prior estimate of $22.73 dated September 11, 2026. These figures represent aggregate analyst targets compiled by Fintel and do not cons

SOURCE: Nasdaq

ORIGINAL REPORT: Click here

DHALLO EDITORIAL STATUS: Aggregated & reviewed

Have feedback on this article?Report error or suggestion

Immix Biopharma Consensus Price Target Increased by 10.16% to $25.04

Read More from Markets

RBI MPC may hike repo rate next week: Experts share the equity-debt strategy investors should consider

Innate Pharma S.A. - Depositary Receipt Price Target Increased by 27.91% to $8.22

Karat Packaging Consensus Price Target Raised 12.05% to $47.43

5 minutes. The news that matters.